SKIP TO CONTENT
About Abbott
Contact
International | eng
Country Language

CARDIOVASCULAR

International | eng
Country Language

EVERY STEP MATTERS

Individualized solutions from start to finish
for coronary artery disease.

Every step matters in coronary artery disease
Access
Gain access with the right guide wir.
Visualize with OCT
OCT Intravascular Imaging
Clear obstacles with orbital atherectomy and dilitation catheters
Diamonback 360
Treat with DES
Xience family of stents
Optimize outcomes with OCT
OCT Intravascular Imaging
Manage hemostasis efficiently
Manage hemostasis efficiently

Every complex case is unique, and no lesion is the same. That’s why we focus on providing the therapies, tools, and specialized knowledge that enable you to tailor your approach and optimize long-term, durable outcomes.
 

divider on page

Individualized Solutions for Calcified Lesions

Calcified lesions present unique challenges that can compromise stent delivery and expansion. 

Abbott’s specialized solutions for coronary calcium empower you in every step from ACCESS to CLOSE:

  • Assess lesion severity using OCT for clear morphological insights.1
  • Prepare and modify tough calcium with dedicated coronary dilatation catheters and atherectomy devices.
  • Achieve durable results2 through thorough lesion preparation and evidence-based therapies, even in complex cases as seen in the results of the pivotal ORBIT II trial.
Explore Solutions for Coronary Calcium
Coronary Calcium

Clear

Evaluate lesion morphology using advanced tools that ensure more accurate and informed decisions.

Calculated

Strategize your treatment and remove obstacles with dedicated solutions to achieve optimal clinical preparation.

Confident

Know your choices are backed by data with strong clinical outcomes and real-world evidence.
 

Coronary artery disease complex cases

References:

  1. Ultreon™ 2.0 Software Instructions for Use (IFU). Refer to IFU for additional information.
  2. Lee M, et al. Orbital atherectomy for treating de novo, severely calcified coronary lesions: 3-year results of the pivotal ORBIT II trial. Cardiovasc Revasc Med. 2017;18(4):261-264.

MAT-2501288 v1.0

POLICIES & ADVISORIES
HEALTHCARE PROFESSIONALS
PATIENTS & CAREGIVERS
Abbott logo

Information contained herein for distribution outside the U.S. only.

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2025 Abbott. All Rights Reserved.

MAT-2001111 v8.0

Disclaimer

You are about to enter an Abbott country- or region-specific website. 

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions

Do you wish to continue and enter this website? 

YES

MAT-2305078 v1.0